Variant report
Variant | esv3416805 |
---|---|
Chromosome Location | chr2:184342157-184345105 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:184335971..184338207-chr2:184339965..184342303,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs576917508 | chr2:184342169-184342170 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs386653381 | chr2:184342216-184342217 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs372731886 | chr2:184342282-184342283 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs114891676 | chr2:184342286-184342287 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs531751772 | chr2:184342333-184342334 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs548149729 | chr2:184342396-184342397 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs540267485 | chr2:184342420-184342421 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs7567519 | chr2:184342453-184342454 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs527616142 | chr2:184342492-184342493 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs547608765 | chr2:184342551-184342552 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs570698312 | chr2:184342557-184342558 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs386653382 | chr2:184342570-184342571 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs114848392 | chr2:184342571-184342572 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs7567725 | chr2:184342579-184342580 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs535417097 | chr2:184342602-184342603 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs554332465 | chr2:184342615-184342616 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs7567749 | chr2:184342631-184342632 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs112339674 | chr2:184342643-184342644 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs575074391 | chr2:184342671-184342672 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs111864119 | chr2:184342676-184342677 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs184531179 | chr2:184342689-184342690 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs556531834 | chr2:184342723-184342724 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs576313775 | chr2:184342736-184342737 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs553907897 | chr2:184342744-184342745 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs577025216 | chr2:184342804-184342805 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs56774845 | chr2:184342858-184342859 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs545863104 | chr2:184342990-184342991 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs563013668 | chr2:184342991-184342992 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs189808176 | chr2:184342998-184342999 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs57157559 | chr2:184343018-184343019 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs12613271 | chr2:184343024-184343025 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs527571300 | chr2:184343027-184343028 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs10931080 | chr2:184343035-184343036 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs564247760 | chr2:184343037-184343038 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs533179475 | chr2:184343097-184343098 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs372136387 | chr2:184343103-184343104 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs12613342 | chr2:184343112-184343113 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs529027470 | chr2:184343209-184343210 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs112054135 | chr2:184343223-184343224 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs13027266 | chr2:184343228-184343229 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs116290150 | chr2:184343252-184343253 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs111980970 | chr2:184343287-184343288 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs181125780 | chr2:184343301-184343302 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs13389804 | chr2:184343349-184343350 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs138787576 | chr2:184343403-184343404 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs112541973 | chr2:184343421-184343422 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs186568108 | chr2:184343430-184343431 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs556506438 | chr2:184343475-184343476 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs552084605 | chr2:184343493-184343494 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs576476870 | chr2:184343510-184343511 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 18522746 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioblastoma | 21080181 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Facial dysmorphism | 20548289 | CNVD |
Mental retardation | 20548289 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21183584 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Autism | 19329560 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:184341600-184342200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
2 | chr2:184341800-184342400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
3 | chr2:184342000-184342200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
4 | chr2:184342000-184342400 | Enhancers | H9 Cell Line | embryonic stem cell |
5 | chr2:184342000-184342400 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
6 | chr2:184342400-184352600 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |